We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Awareness Technology, Inc.

Awareness Technology, Inc. provides clinical laboratory instrumentation, reagents and assays for small-to-medium-volu... read more Featured Products: More products

Download Mobile App





Awareness Technology Showcases Range of Cutting-Edge Analyzers

By LabMedica International staff writers
Posted on 12 Nov 2024

Awareness Technology, Inc. More...

(Palm City, FL, USA) is showcasing its advanced analyzers at MEDICA 2024 where these instruments are available for hands-on demonstrations during the show.

At this year’s MEDICA, Awareness is presenting the ChemWell 2 two-plate ELISA/chemiluminescent analyzer for running a variety of applications. The instrument’s ability to mix a wide range of ELISA/CLIA assays on two microwell plates provides a level of flexibility that makes the ChemWell 2 an excellent choice for laboratories. Awareness is also showcasing the ChemWell RPR Automated RRP Analyzer for serum syphilis screening that utilizes a sophisticated camera system designed to capture high-resolution images of the reactions. It features specialized software that analyzes the image, providing an accurate and objective reading of the reaction as reactive or non-reactive.

Also being presented at the show are the enhanced Stat Fax 4500 biochemistry analyzer and Stat Fax 4700 ELISA strip reader which have recently received upgraded screens, faster processors, and new user interfaces. At the heart of the Stat Fax 4500 and 4700 is a new and faster micro-processor and significantly increased memory capacity. All the calculation modes, reporting functions, and the ability to customize test parameters remain the same but function faster. A new feature of the instruments’ improved memory capacity is their ability to store over 140 programmed tests. Their new interface features a high-resolution backlit display with a capacitive touch screen that has the responsiveness of a smartphone with no need for a stylus to make accurate selections. Screens are updated almost instantly with a new menu system driven by icons designed to intuitively identify their functions.

At MEDICA 2024, Awareness is also introducing its latest instrument, the Chemi+ biochemistry analyzer designed to optimize laboratory efficiency. This compact device boasts a small footprint, making it an ideal choice for labs with limited space. The Chemi+ is complemented by user-friendly software, ensuring seamless operation for lab technicians of all skill levels. A standout feature of the Chemi+ is its open system capability, which allows for wireless management of up to four Chemi+ analyzers through a single tablet or PC. This integration not only simplifies workflow but also enhances productivity by enabling simultaneous multi-device operation. The Chemi+ biochemistry analyzer is poised to set a new standard in laboratory technology, combining efficiency, ease of use, and advanced connectivity in a compact design.

Related Links:
Awareness Technology, Inc.


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Mini Vortex Mixer
Vornado
New
Hepatitis A Rapid Test
Anti-HAV IgM Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.